iTeos Therapeutics, Inc. (ITOS) earnings
Quarterly and annual ITOS reports and results, each read against the price at its own news timestamp. Back to the ITOS overview →
9 measured ITOS earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q iTeos Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.15% | +0.20% | |
| Form 10-Q iTeos Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.55% | -5.39% | |
| Form 10-K iTeos Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.46% | +6.14% | |
| Form 10-Q iTeos Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -3.53% | -4.57% | |
| Form 10-Q iTeos Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.55% | -3.45% | |
| Form 10-Q iTeos Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.79% | +4.12% | |
| iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates | Press release | +0.79% | +4.12% | |
| Form 10-K iTeos Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | +5.69% | |
| Form 10-Q iTeos Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +4.31% | +3.20% |
Keep exploring
More ITOS: analyst actions → · SEC filings → · ITOS overview →